Absci Corporation (ABSI) vs Stoke Therapeutics, Inc. (STOK)
- Absci Corporation ABSI 8.25 −7.09%
- Stoke Therapeutics, Inc. STOK 24.17 −1.79%
Absci Corporation and Stoke Therapeutics, Inc. are both Biotechnology companies. Absci Corporation and Stoke Therapeutics, Inc. are of similar size ($1.6B and $1.5B). Absci Corporation grew revenue faster over the last twelve months: −62.3% against −86.2%. Stoke Therapeutics, Inc. has the higher net margin (−753.6% vs −7,756.4%) and the lower return on invested capital (−264.8% vs −174.7%). Across the 16 metrics below, Absci Corporation leads on 8 and Stoke Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | ABSI | STOK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (8,084.50%) | (809.69%) | 0.00% |
| Net margin | (7,756.37%) | (753.60%) | 0.00% |
| Free cash flow margin | (6,969.83%) | (654.92%) | 0.00% |
| Return on equity | (57.72%) | (61.10%) | (56.36%) |
| Return on assets | (50.57%) | (53.41%) | (48.04%) |
| Return on invested capital | (174.74%) | (264.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack